Preliminary results from a first-in-human phase 1 dose escalation trial of ADRX-0706, a next generation Nectin-4 ADC, in subjects with advanced solid tumors.

ADRX-0706 - Adcentrx Therap

IMC001 - Immunofoco

https://meetings.asco.org/abstracts-presentations/246512/

Alexandra Drakaki; Justin Call; Sreenivasa Chandana; Jordi Rodon Ahnert; Anthony El-Khoueiry; Drew Rasco; Benjamin Garmezy; Guiling Li; Shudong Zhang; Yu Chen; Abraham Fong; Pia Challita-Eid; Hui Li; Ye Guo

Apr 23, 2025